BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26385817)

  • 1. Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.
    Morton RL; Schlackow I; Staplin N; Gray A; Cass A; Haynes R; Emberson J; Herrington W; Landray MJ; Baigent C; Mihaylova B;
    Am J Kidney Dis; 2016 Jan; 67(1):31-9. PubMed ID: 26385817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).
    Mihaylova B; Schlackow I; Herrington W; Lozano-Kühne J; Kent S; Emberson J; Reith C; Haynes R; Cass A; Craig J; Gray A; Collins R; Landray MJ; Baigent C;
    Am J Kidney Dis; 2016 Apr; 67(4):576-84. PubMed ID: 26597925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP).
    Staplin N; Haynes R; Herrington WG; Reith C; Cass A; Fellström B; Jiang L; Kasiske BL; Krane V; Levin A; Walker R; Wanner C; Wheeler DC; Landray MJ; Baigent C; Emberson J;
    Am J Kidney Dis; 2016 Sep; 68(3):371-80. PubMed ID: 27118687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ricardo AC; Anderson CA; Yang W; Zhang X; Fischer MJ; Dember LM; Fink JC; Frydrych A; Jensvold NG; Lustigova E; Nessel LC; Porter AC; Rahman M; Wright Nunes JA; Daviglus ML; Lash JP;
    Am J Kidney Dis; 2015 Mar; 65(3):412-24. PubMed ID: 25458663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Plant-Based Diets and Risk of CKD Progression and All-Cause Mortality: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Amir S; Kim H; Hu EA; Ricardo AC; Mills KT; He J; Fischer MJ; Pradhan N; Tan TC; Navaneethan SD; Dobre M; Anderson CAM; Appel LJ; Rebholz CM;
    Am J Kidney Dis; 2024 May; 83(5):624-635. PubMed ID: 38103719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.
    Reith C; Staplin N; Herrington WG; Stevens W; Emberson J; Haynes R; Mafham M; Armitage J; Cass A; Craig JC; Jiang L; Pedersen T; Baigent C; Landray MJ;
    BMC Nephrol; 2017 May; 18(1):147. PubMed ID: 28460629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease.
    Sharp Collaborative Group
    Am Heart J; 2010 Nov; 160(5):785-794.e10. PubMed ID: 21095263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.
    Stanifer JW; Charytan DM; White J; Lokhnygina Y; Cannon CP; Roe MT; Blazing MA
    J Am Soc Nephrol; 2017 Oct; 28(10):3034-3043. PubMed ID: 28507057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Informed and Activated Patient: Addressing Barriers in the Pathway From Education to Outcomes.
    Wright Nunes JA; Cavanaugh KL; Fagerlin A
    Am J Kidney Dis; 2016 Jan; 67(1):1-4. PubMed ID: 26708191
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lowering LDL cholesterol on progression of kidney disease.
    Haynes R; Lewis D; Emberson J; Reith C; Agodoa L; Cass A; Craig JC; de Zeeuw D; Feldt-Rasmussen B; Fellström B; Levin A; Wheeler DC; Walker R; Herrington WG; Baigent C; Landray MJ; ;
    J Am Soc Nephrol; 2014 Aug; 25(8):1825-33. PubMed ID: 24790178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
    Heart Protection Study Collaborative Group
    Lancet; 2002 Jul; 360(9326):7-22. PubMed ID: 12114036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
    Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations in Applying the Results of Randomized Controlled Clinical Trials to the Care of Older Adults With Kidney Disease in the Clinical Setting: The SHARP Trial.
    Butler CR; O'Hare AM
    Adv Chronic Kidney Dis; 2016 Jan; 23(1):29-35. PubMed ID: 26709060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease.
    Herrington W; Staplin N; Judge PK; Mafham M; Emberson J; Haynes R; Wheeler DC; Walker R; Tomson C; Agodoa L; Wiecek A; Lewington S; Reith CA; Landray MJ; Baigent C;
    Hypertension; 2017 Feb; 69(2):314-322. PubMed ID: 28028192
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.